VOYA Investment Management’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-7,764
| Closed | -$76.4K | – | 2960 |
|
|
2023
Q1 | $76.4K | Hold |
7,764
| – | – | ﹤0.01% | 2744 |
|
|
2022
Q4 | $145K | Sell |
7,764
-78,254
| -91% | -$1.77M | ﹤0.01% | 2660 |
|
|
2022
Q3 | $1.78M | Buy |
86,018
+79,284
| +1,177% | +$2.03M | ﹤0.01% | 1366 |
|
|
2022
Q2 | $140K | Hold |
6,734
| – | – | ﹤0.01% | 2529 |
|
|
2022
Q1 | $290K | Hold |
6,734
| – | – | ﹤0.01% | 2192 |
|
|
2021
Q4 | $403K | Sell |
6,734
-50
| -0.7% | -$4.01K | ﹤0.01% | 2137 |
|
|
2021
Q3 | $583K | Hold |
6,784
| – | – | ﹤0.01% | 1950 |
|
|
2021
Q2 | $755K | Sell |
6,784
-37
| -0.5% | -$3.55K | ﹤0.01% | 1835 |
|
|
2021
Q1 | $760K | Buy |
6,821
+1,121
| +20% | +$147K | ﹤0.01% | 1769 |
|
|
2020
Q4 | $605K | Buy |
5,700
+1,269
| +29% | +$169K | ﹤0.01% | 1792 |
|
|
2020
Q3 | $617K | Buy |
4,431
+279
| +7% | +$58.2K | ﹤0.01% | 1541 |
|
|
2020
Q2 | $1.34M | Buy |
4,152
+130
| +3% | +$20.9K | ﹤0.01% | 1154 |
|
|
2020
Q1 | $359K | Sell |
4,022
-55
| -1% | -$3.39K | ﹤0.01% | 1818 |
|
|
2019
Q4 | $161K | Buy |
4,077
+823
| +25% | +$24.8K | ﹤0.01% | 2446 |
|
|
2019
Q3 | $80K | Hold |
3,254
| – | – | ﹤0.01% | 2445 |
|
|
2019
Q2 | $115K | Buy |
3,254
+407
| +14% | +$16.2K | ﹤0.01% | 2433 |
|
|
2019
Q1 | $127K | Hold |
2,847
| – | – | ﹤0.01% | 2376 |
|
|
2018
Q4 | $137K | Buy |
2,847
+187
| +7% | +$11.4K | ﹤0.01% | 2334 |
|
|
2018
Q3 | $177K | Hold |
2,660
| – | – | ﹤0.01% | 2378 |
|
|
2018
Q2 | $125K | Sell |
2,660
-334
| -11% | -$18.4K | ﹤0.01% | 2475 |
|
|
2018
Q1 | $169K | Hold |
2,994
| – | – | ﹤0.01% | 2368 |
|
|
2017
Q4 | $148K | Hold |
2,994
| – | – | ﹤0.01% | 2430 |
|
|
2017
Q3 | $228K | Buy |
2,994
+377
| +14% | +$28.1K | ﹤0.01% | 2320 |
|
|
2017
Q2 | $246K | Buy |
2,617
+317
| +14% | +$27.1K | ﹤0.01% | 2288 |
|
|
2017
Q1 | $183K | Hold |
2,300
| – | – | ﹤0.01% | 2304 |
|
|
2016
Q4 | $192K | Hold |
2,300
| – | – | ﹤0.01% | 2310 |
|
|
2016
Q3 | $257 | Hold |
2,300
| – | – | ﹤0.01% | 2138 |
|
|
2016
Q2 | $255K | Hold |
2,300
| – | – | ﹤0.01% | 2118 |
|
|
2016
Q1 | $240K | Hold |
2,300
| – | – | ﹤0.01% | 2126 |
|
|
2015
Q4 | $185K | Hold |
2,300
| – | – | ﹤0.01% | 2307 |
|
|
2015
Q3 | $160K | Sell |
2,300
-648
| -22% | -$56.5K | ﹤0.01% | 2356 |
|
|
2015
Q2 | $289K | Hold |
2,948
| – | – | ﹤0.01% | 2289 |
|
|
2015
Q1 | $289K | Hold |
2,948
| – | – | ﹤0.01% | 2246 |
|
|
2014
Q4 | $325K | Hold |
2,948
| – | – | ﹤0.01% | 2208 |
|
|
2014
Q3 | $348K | Hold |
2,948
| – | – | ﹤0.01% | 2154 |
|
|
2014
Q2 | $382K | Buy |
+2,948
| New | +$348K | ﹤0.01% | 2185 |
|
Other funds holding INO
VOYA Investment Management's INO Position: Q2 2023 in Review
VOYA Investment Management sold out of Inovio Pharmaceuticals (INO) in Q2 2023, closing a stake of 7,764 shares — an estimated $76.4K sold.
VOYA Investment Management first reported a position in INO in Q2 2014 and held it in 36 quarters. The position peaked at $1.78M in Q3 2022. 133 funds tracked by Wall St. Rank hold INO as of Q2 2023.
- VOYA Investment Management reported no remaining Inovio Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
- VOYA Investment Management sold 7,764 Inovio Pharmaceuticals shares in Q2 2023, an estimated $76.4K.
- VOYA Investment Management first reported a position in Inovio Pharmaceuticals in Q2 2014 and held it in 36 quarters.
- VOYA Investment Management's Inovio Pharmaceuticals position peaked at $1.78M in Q3 2022.
- 133 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2023.
Based on VOYA Investment Management's 13F filing for Q2 2023, filed 14 Aug 2023.